We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+7.09%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$55.6M
Cap. Flow
-$39M
Cap. Flow %
-19.4%
Top 10 Hldgs %
65.11%
Holding
117
New
29
Increased
11
Reduced
11
Closed
37

Top Buys

Rank Stock Value
1
HIMX
Himax Technologies
HIMX
+$4.16M
2
DSKY
IDREAMSKY TECHNOLOGY LTD ADS REPTSG SHS CL A
DSKY
+$3.61M
3
BIDU icon
Baidu
BIDU
+$3.17M
4
ADPT
Adeptus Health Inc
ADPT
+$2.61M
5
PCYC
PHARMACYCLICS INC
PCYC
+$1.71M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$45.8M
2
VSA
VisionSys AI
VSA
+$3.8M
3
VIPS icon
Vipshop
VIPS
+$2.47M
4
RVNC
Revance Therapeutics, Inc.
RVNC
+$1.7M
5
QLTY
QUALITY DISTR INC FLA
QLTY
+$1.49M

Sector Composition

Rank Sector Weight
1 Miscellaneous 57.03%
2 Healthcare 16.21%
3 Technology 7.4%
4 Communication Services 5.85%
5 Consumer Discretionary 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JOYY
26
JOYY Inc
JOYY
$3.78B
$1.5M 0.75%
+20,000
New +$1.63M
EXAS
27
DELISTED
Exact Sciences
EXAS
$1.36M 0.68%
+70,000
New +$1.28M
MEI icon
28
Methode Electronics
MEI
$469M
$1.29M 0.64%
35,000
-15,000
-30% -$532K
RNA
29
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$1.26M 0.63%
150,000
+70,000
+88% +$663K
TSLA icon
30
Tesla
TSLA
$1.41T
$1.21M 0.6%
+75,000
New +$1.24M
NEOG icon
31
Neogen
NEOG
$2.67B
$1.19M 0.59%
+80,000
New +$1.26M
CSII
32
DELISTED
Cardiovascular Systems, Inc.
CSII
$1.18M 0.59%
50,000
– –
EDU icon
33
New Oriental
EDU
$8.95B
$1.16M 0.58%
+50,000
New +$1.11M
HCSG icon
34
Healthcare Services Group
HCSG
$1.5B
$1.14M 0.57%
+40,000
New +$1.11M
CELG
35
DELISTED
Celgene Corp
CELG
$1.14M 0.57%
12,000
– –
IDTI
36
DELISTED
Integrated Device Technology I
IDTI
$1.12M 0.56%
70,000
-10,000
-13% -$155K
SPNC
37
DELISTED
Spectranetics Corp
SPNC
$1.06M 0.53%
40,000
– –
TAL icon
38
TAL Education Group
TAL
$6.52B
$1.05M 0.52%
180,000
+30,000
+20% +$159K
ADMS
39
DELISTED
Adamas Pharmaceuticals
ADMS
$1.04M 0.52%
+61,813
New +$1.06M
VSA
40
VisionSys AI
VSA
$7.85M
$1.03M 0.51%
32
-116
-78% -$3.8M
ASPX
41
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$1.03M 0.51%
+40,000
New +$851K
TNAV
42
DELISTED
Telenav Inc.
TNAV
$1M 0.5%
+150,000
New +$920K
ENTA icon
43
Enanta Pharmaceuticals
ENTA
$358M
$989K 0.49%
25,000
– –
PCRX icon
44
Pacira BioSciences
PCRX
$960M
$969K 0.48%
10,000
– –
PBYI icon
45
Puma Biotechnology
PBYI
$477M
$954K 0.48%
4,000
– –
BABA icon
46
Alibaba
BABA
$272B
$889K 0.44%
+10,000
New +$898K
ATML
47
DELISTED
ATMEL CORP
ATML
$808K 0.4%
100,000
– –
TTPH
48
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$798K 0.4%
+2,000
New +$536K
ESPR
49
DELISTED
Esperion Therapeutics
ESPR
$734K 0.37%
+30,000
New +$477K
PTCT icon
50
PTC Therapeutics
PTCT
$5.48B
$713K 0.36%
+16,200
New +$507K
1
2
3 4 5

Similar funds

MAM
Moelis Asset Management New York $5.32M AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
SM
SG3 Management Dorado, Puerto Rico $6.45K AUM 61.81% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

Granite Point Capital Management's Q3 2014 Portfolio in Review

As of Q3 2014, Granite Point Capital Management held 117 positions worth $201M, up 38% from $145M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Granite Point Capital Management withdrew a net $39M in Q3 2014, closing 37 positions and reducing 11 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $45.8M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, up from 45% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Granite Point Capital Management opened a new position in Himax Technologies worth $5.58M.

  • Granite Point Capital Management's largest Q3 2014 buy was Himax Technologies: 550,000 shares worth $5.58M.
  • Granite Point Capital Management added most to Ariad Pharmaceuticals Inc in Q3 2014, an estimated $1.46M increase.
  • Granite Point Capital Management's biggest Q3 2014 reduction was VisionSys AI, cutting an estimated $3.8M.
  • Granite Point Capital Management fully exited iShares Russell 2000 ETF in Q3 2014, selling an estimated $45.8M.
  • Granite Point Capital Management's ten largest holdings make up 65% of its $201M portfolio in Q3 2014.
  • Granite Point Capital Management opened 29 new positions and closed 37 in Q3 2014.
  • Granite Point Capital Management's portfolio value rose 38% quarter-over-quarter to $201M.

Based on Granite Point Capital Management's 13F filing for Q3 2014, filed 13 Nov 2014.